Leslie, W.D. http://orcid.org/0000-0002-1056-1691
Schousboe, J.T.
Morin, S.N.
Martineau, P.
Lix, L.M.
Johansson, H.
McCloskey, E.V.
Harvey, N.C.
Kanis, J.A. http://orcid.org/0000-0002-3129-4326
Article History
Received: 27 October 2019
Accepted: 22 January 2020
First Online: 3 February 2020
Compliance with ethical standards
:
: Suzanne Morin: Nothing to declare for the context of this paper, but has received research grants: Amgen.Eugene McCloskey: Nothing to declare for the context of this paper, but numerous ad hoc consultancies/speaking honoraria and/or research funding from Amgen, Bayer, General Electric, GSK, Hologic, Lilly, Merck Research Labs, Novartis, Novo Nordisk, Nycomed, Ono, Pfizer, ProStrakan, Roche, Sanofi-Aventis, Servier, Tethys, UBS, and Warner-Chilcott.Nicholas Harvey: Nothing to declare for the context of this paper, but has received consultancy/lecture fees/honoraria/grant funding from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Servier, Shire, Consilient Healthcare, Radius Health, UCB, Kyowa Kirin, and Internis Pharma.John A. Kanis: Grants from Amgen, Lilly, Radius Health and non-financial support from Medimaps outside the submitted work.William Leslie, Patrick Martineau, Lisa Lix, Helena Johansson: No conflicts of interest.
: The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, Manitoba Health, Seniors and Active Living, or other data providers is intended or should be inferred. This article has been reviewed and approved by the members of the Manitoba Bone Density Program Committee.